Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12‐months results
Authors:
- 9 September 2015
- journal article
- research article
- Published by Wiley in Neurourology and Urodynamics
- Vol. 36 (1) , 104-110
Abstract
Aims: The aim of this study is to determine the sustained therapeutic efficacy and treatment intervals for PTNS in NOAB with MS, offering periodic additional treatments during 1 year in patients who completed an initial course of 12 consecutive weekly sessions.Methods: A total of 34 patients enrolled to the PTNS treatment and 21 patients completed the 1 year PTNS treatment with a tapering protocol of 6, 9, and 12 months of therapy, respectively. After 12 weeks of therapy, PTNS was applied at 14 day intervals for 3 months, 21 day intervals for 3 months, and 28 day intervals for 3 months. The patients completed a 3‐day voiding diary at 3rd, 6th, 9th, and 12th month. The patients requested to complete validated questionnaires (ICIQ‐SF, OAB‐V8, OAB‐q SF) were carried out within 3‐month intervals thereafter during their enrolment in the study.Results: A total of 21 patients were enrolled in the study. Of these 5 (23.8%) were men and 16 (76.2%) women. The improvements for all voiding diary parameters were significant in the 6th, 9th, and 12th months when compared with baseline. Mean values between baseline and 12 month parameters suggested that daytime frequency decreased by 5.4 voids daily, urge incontinence decreased by 3.4 episodes daily, urgency episodes decreased by 7.4 episodes daily, nocturia decreased by 2.6 voids, and voided volume improved by a mean of 72.1 cc.Conclusion: These results have demonstrated NOAB symptom improvement in MS patients can be achieved with 12 weekly PTNS treatments which show excellent durability over 12 months. Neurourol. Urodynam. 36:104–110, 2017.Keywords
This publication has 27 references indexed in Scilit:
- Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24‐month results of the STEP studyNeurourology and Urodynamics, 2012
- InterStim Sacral Neuromodulation and Botox Botulinum-A Toxin Intradetrusor Injections for Refractory Urge Urinary IncontinenceUrogynecology, 2011
- Tibial nerve stimulation for overactive bladder syndrome unresponsive to medical therapyJournal of Obstetrics and Gynaecology, 2010
- The clinical and urodynamic results of a 3‐month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis‐related neurogenic bladder dysfunctionNeurourology and Urodynamics, 2009
- Percutaneous tibial nerve stimulation produces effects on brain activity: Study on the modifications of the long latency somatosensory evoked potentialsNeurourology and Urodynamics, 2008
- Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's diseaseNeurourology and Urodynamics, 2008
- BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDYJournal of Urology, 2005
- Relationship of Bladder Dysfunction to Lesion Site in Multiple SclerosisJournal of Urology, 2003
- POSTERIOR TIBIAL NERVE STIMULATION AS NEUROMODULATIVE TREATMENT OF LOWER URINARY TRACT DYSFUNCTIONJournal of Urology, 2001
- ELECTROACUPUNCTURE DECREASES C-FOS EXPRESSION IN THE SPINAL CORD INDUCED BY NOXIOUS STIMULATION OF THE RAT BLADDERJournal of Urology, 1998